- Home
- XERS vs QUBT Comparison
XERS vs QUBT Comparison
Compare XERS & QUBT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | XERS | QUBT |
|---|---|---|
| Founded | 2005 | 2001 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Computer Manufacturing |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.5B | 1.7B |
| IPO Year | 2021 | 2019 |
Fundamental Metrics
Financial Performance| Metric | XERS | QUBT |
|---|---|---|
| Price | $8.23 | $7.79 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 6 | 6 |
| Target Price | $10.83 | ★ $17.50 |
| AVG Volume (30 Days) | 1.9M | ★ 9.0M |
| Earning Date | 05-07-2026 | 05-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 100.00 | 84.93 |
| EPS | ★ 0.01 | N/A |
| Revenue | ★ $49,590,000.00 | $682,000.00 |
| Revenue This Year | $34.37 | $3,210.56 |
| Revenue Next Year | $22.86 | $51.26 |
| P/E Ratio | $821.00 | ★ N/A |
| Revenue Growth | ★ 142.67 | 82.84 |
| 52 Week Low | $4.87 | $6.18 |
| 52 Week High | $10.08 | $25.84 |
Technical Indicators
Market Signals| Indicator | XERS | QUBT |
|---|---|---|
| Relative Strength Index (RSI) | 54.38 | 41.51 |
| Support Level | $8.00 | $6.18 |
| Resistance Level | $8.42 | $13.08 |
| Average True Range (ATR) | 0.33 | 0.49 |
| MACD | -0.11 | 0.01 |
| Stochastic Oscillator | 24.00 | 23.89 |
Price Performance
Historical ComparisonAbout XERS Xeris Biopharma Holdings Inc.
Xeris Biopharma Holdings Inc is a commercial-stage biopharmaceutical company focused on developing and commercializing therapies for people with chronic endocrine and neurological diseases in the United States. It offers Recorlev for the treatment of endogenous hypercortisolemia in patients with Cushing's syndrome; Gvoke for the treatment of severe hypoglycemia; and Keveyis for the treatment of Primary Periodic Paralysis (PPP). Additionally, the company is advancing its Phase 3-ready pipeline product, XP-8121, a once-weekly subcutaneous injection of levothyroxine, which leverages its proprietary technology, XeriSol.
About QUBT Quantum Computing Inc.
Quantum Computing Inc is an integrated photonics and non-linear quantum optics company to develop and deliver machines for quantum computing, reservoir computing, and remote sensing, imaging, and cybersecurity applications based on patented and proprietary photonics technology. Its products are designed to operate at room temperature and low power at an affordable cost. The Company's portfolio of core technologies and products offers capabilities in the areas of high-performance computing, artificial intelligence, and cybersecurity, as well as remote sensing applications.